Skip to main content
Premium Trial:

Request an Annual Quote

NanoString Technologies, OHSU Partner on Breast Cancer Spatial Protein Profiling Assay Development

NEW YORK – NanoString Technologies and Oregon Health & Science University on Tuesday announced a collaboration to develop GeoMx Digital Spatial Profiler-based protein assays for breast cancer.

Under the terms of the deal, pathologists at OHSU will design a new GeoMx protein assay with up to 30 targets, including existing diagnostic markers and novel biomarker candidates. They will analytically and clinically validate this and other assays for potential use as laboratory-developed tests. Financial and other details were not disclosed.

"The development of novel GeoMx DSP protein assays expands the potential applications of spatial biology with the goal of providing better patient care through advanced molecular testing," Christopher Corless, executive director of the Knight Diagnostic Laboratories at the OHSU Knight Cancer Institute, said in a statement. "The GeoMx DSP platform is uniquely suited for this work based on the high-plex and automated capabilities of the system for use with formalin-fixed paraffin-embedded samples."

NanoString recently launched GeoMx protein assays with next-generation sequencing readout. The deal comes as the firm is trying to broaden the market for GeoMx, which can also perform spatial gene expression analysis.

Last year, NanoString partnered with Mayo Clinic Laboratories to develop clinical breast cancer tests on the GeoMx and nCounter platforms.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.